PRAME expression and histology impact survival in first-line NSCLC

Histology-specific PRAME expression profiles influence survival in lung cancer patients

INDICATION
Lung
BIOMARKER
PRAME

Kaplan-Meier survival curves for four PRAME and histology groups over time.
rwPFS in NSCLC patients treated with chemotherapy +IO in 1L. Stratification by PRAME expression (high v. low) and histology type (adeno v. squamous).

Related cases

Icon with three vertical bars and a circle, resembling a bar graph or LinkedIn logo.Lens Library
Grid displaying data points with blue, black, and gray squares on a white background.

RB1 loss-of-function mutations in post-Osimertinib NSCLC and prognostic implications

2026-07-01
Lung
RB1
Icon with three vertical bars and a circle, resembling a bar graph or LinkedIn logo.Lens Library
Abstract grid of small blue, gray, black, and orange squares on a white background.

Tracking PPM1D post-treatment prevalence to evaluate prognosis in lung adenocarcinoma

2026-07-01
Lung
PPM1D
Icon with three vertical bars and a circle, resembling a bar graph or LinkedIn logo.Lens Library
A pixelated grid displaying shades of blue with small, scattered multi-colored squares.

Impact of pre- and post-treatment ctDNA positivity on outcomes in NSCLC

2026-05-26
Lung
ctDNA